Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan

Blood Transfusion

Volumn 11, Issue 1, 2013, Pages 71-74

  Chao, Yu Hua ^a,b   Wu, Kang Hsi ^c,d   Lu, Jang Jih ^c   Shih, Mu Chin ^c,d   Peng, Ching Tien ^c,d,e   Chang, Ci Wen ^c,d  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

Author keywords

Alloimmunisation; Chinese; Leucodepletion; Thalassaemia; Transfusion

Indexed keywords

ALLOANTIBODY; DIPHENHYDRAMINE; MI ANTIBODY; PARACETAMOL; RHESUS C ANTIBODY; RHESUS E ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLOIMMUNITY; ALLOIMMUNIZATION; ANTIBODY SCREENING; ARTICLE; BLOOD TRANSFUSION REACTION; CHINESE; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; RASH; RETROSPECTIVE STUDY; SPLENECTOMY; TAIWAN; THALASSEMIA MAJOR; TREATMENT DURATION;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BETA-THALASSEMIA; BLOOD GROUP INCOMPATIBILITY; CHILD; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HUMANS; ISOANTIBODIES; MALE; RETROSPECTIVE STUDIES; TAIWAN;

EID: 84872246611     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.0153-11     Document Type: Article

References (20)

1. Chang HH, Lu MY, Liao YM, et al. Improved efficacy and tolerability of oral deferasirox by twice-daily dosing for patients with transfusion-dependent beta-thalassemia. Pediatr Blood Cancer 2011; 56: 420-4.
2. Galanello R, Agus A, Campus S, et al. Combined iron chelation therapy. Ann N Y Acad Sci 2010; 1202: 79-86.
3. El Alfy M, Sari TT, Lee CL, et al. The safety, tolerability, and efficacy of a liquid formulation of deferiprone in young children with transfusional iron overload. J Pediatr Hematol Oncol 2010; 32: 601-5.
4. Balocco M, Carrara P, Pinto V, Forni GL. Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients. Am J Hematol 2010; 85: 460-1.
5. Peng CT, Chow KC, Chen JH, et al. Safety monitoring of cardiac and hepatic systems in beta-thalassemia patients with chelating treatment in Taiwan. Eur J Haematol 2003; 70: 392-7.
6. Karimi M, Nikrooz P, Kashef S, et al. RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran. Int J Lab Hematol 2007; 29: 321-6. (Pubitemid 47373619)
7. Lin M, Br oadberry RE, Chang GJ. The distribution of blood group antigens and alloantibodies among Chinese in Taiwan. Transfusion 1988; 28: 350-
8. Wu KH, Ch ang JG, Ho YJ, et al. Glutathione S-transferase M1 gene polymorphisms are associated with cardiac iron deposition in patients with beta-thalassemia major. Hemoglobin 2006; 30: 251-6.
9. Pahuja S, Pujani M, Gupta SK, et al. Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology 2010; 15: 174-7.
10. Ameen R, Al-Shemmari S, Al-Humood S, et al. RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion 2003; 43: 1604-10. (Pubitemid 37371832)
11. Blumberg N, Heal JM, Gettings KF. WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion 2003; 43: 945-52. (Pubitemid 36753945)
12. Singer S T, Wu V, Mignacca R, et al. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood 2000; 96: 3369-73.
13. Michail-Merianou V, Pamphili-Panousopoulou L, Piperi-Lowes L, et al. Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes. Vox Sang 1987; 52: 95-8. (Pubitemid 17052796)
14. a, a red blood cell alloantibody, in Taiwan. Vox Sang 2002; 83: 162-4.
15. Chen J, Hu C, Lin K, et al. Analysis antibody identification data from blood donation and transfusion services in Kaohsiung. J Biomed Lab Sci 2007; 19: 99-105.
16. Chang F, Chan Y, Wang C, et al. Frequency of alloantibodies in patients in Mackay Memorial Hospital. Formosan J Med 2004; 8: 755-9.
17. Jan RH, Yu LC, Wen SH, et al. Incidence of alloantibodies in transfused patients in eastern Taiwan. Tzu Chi Med J 2009; 21: 66-9.
18. Wang LY, Liang DC, Liu HC, et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfus Med 2006; 16: 200-3.
19. Smit Sib inga CT. Immune effects of blood transfusion. Curr Opin Hematol 1999; 6: 442-5.
20. Blajchma n MA. Immunomodulatory effects of allogenic blood transfusions: clinical manifestations and mechanisms. Vox Sang 1998; 74: 315-9.